EUVIMEDEUVIMED entdecken
Multizentrische Studie

Laboratory Concordance and Prognostic Impact of 10‐Color Flow Cytometry and Next‐Generation Sequencing‐Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B‐Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group ( TALWG )

Chantiya Chanswangphuwana iD, Wasithep Limvorapitak iD, Sirorat Kobbuaklee iD, Patsita Kansuwan, Kitsada Wudhikarn iD, Ponlapat Rojnuckarin iD, Weerapat Owattanapanich iD, Thanawat Rattanathammethee iD, Adisak Tantiworawit iD, Panachai Silpsamrit iD, Kannadit Prayongratana iD, Thanakrit Piyajaroenkij und 2 weitere

International Journal of Laboratory Hematology · 2026-12 · 48 (6) · 1418-1427

DOI: 10.1111/ijlh.70216 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 09.08.2026. Verfasst von Chantiya Chanswangphuwana und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thai…. Hauptthemen laut MEDLINE: Flow Cytometry, High-Throughput Nucleotide Sequencing, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Genes, Immunoglobulin. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Medical Council of Thailand, Thai Society of Hematology, Center of Excellence in Translational Hematology, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Measurable residual disease (MRD) is a key prognostic marker for patient survival. This study evaluated concordance between 10‐color flow cytometry and next‐generation sequencing (NGS)–based immunoglobulin heavy chain (IGH) gene assays for MRD detection and to assess prognostic significance in adult B‐cell acute lymphoblastic leukemia (B‐ALL).

Methods

This multicenter prospective study enrolled 51 patients with newly diagnosed B‐ALL. Bone marrow samples were obtained at diagnosis, post‐induction (1 month), and post–early consolidation (3 months). Flow cytometry and NGS‐IGH were performed at three timepoints to assess MRD B‐ALL.

Results

Patients were classified as high risk according to white blood cell count and cytogenetic features in 37.3% and 64.7% of patients, respectively. Treatment protocols included pediatric‐inspired regimens (41.2%), adult‐ALL protocols (52.9%), and low‐intensity chemotherapy. All 16 Philadelphia chromosome–positive patients received tyrosine kinase inhibitors. Twenty patients underwent allogeneic hematopoietic cell transplantation (HCT) in first complete remission (CR). Median relapse‐free survival (RFS) and overall survival were 19 and 39 months, respectively. MRD negativity at 3 months by either method correlated with significantly superior RFS. Allogeneic HCT also conferred RFS benefit. MRD positive patients without HCT had the worst RFS. Flow cytometry MRD positivity at 3 months independently predicted inferior RFS (HR 3.81; 95% CI 1.01–14.43). The overall concordance between flow cytometry and NGS was 80.7%.

Conclusion

MRD positivity at 3 months post‐treatment strongly predicted relapse, supporting its use to guide therapeutic modifications of B‐ALL. Apart from NGS‐based IGH clonality assays, 10‐color flow cytometry offers an alternative in resource‐limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryHigh-Throughput Nucleotide SequencingPrecursor B-Cell Lymphoblastic Leukemia-LymphomaGenes, ImmunoglobulinHumansNeoplasm, ResidualAdultFemaleMalePrognosisMiddle AgedAdolescentProspective StudiesYoung AdultAged

Stichwörter der Autor:innen

acute lymphoblastic leukemiaflow cytometryimmunoglobulin gene rearrangementmeasurable residual diseasenext‐generation sequencing

Autor:innen und Institutionen

  • Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Center of Excellence in Translational Hematology, Chulalongkorn University, Bangkok, Thailand.
  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
  • Division of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Hematology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.

ORCID-Profile: Chantiya Chanswangphuwana, Wasithep Limvorapitak, Sirorat Kobbuaklee, Kitsada Wudhikarn, Ponlapat Rojnuckarin, Weerapat Owattanapanich, Thanawat Rattanathammethee, Adisak Tantiworawit, Panachai Silpsamrit, Kannadit Prayongratana, Dusit Jit-Ueakul, Chantana Polprasert

Förderung

  • Medical Council of Thailand
  • Thai Society of Hematology
  • Center of Excellence in Translational Hematology, Chulalongkorn University
  • Ratchadapiseksompotch Research Fund

Zitieren

APA

Chanswangphuwana, C., Limvorapitak, W., Kobbuaklee, S., Kansuwan, P., Wudhikarn, K., Rojnuckarin, P., Owattanapanich, W., Rattanathammethee, T., Tantiworawit, A., Silpsamrit, P., Prayongratana, K., Piyajaroenkij, T., Jit-Ueakul, D., & Polprasert, C. (2026). Laboratory Concordance and Prognostic Impact of 10‐Color Flow Cytometry and Next‐Generation Sequencing‐Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B‐Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group ( TALWG ). International Journal of Laboratory Hematology, 48(6), 1418-1427. https://doi.org/10.1111/ijlh.70216

Vancouver

Chanswangphuwana C, Limvorapitak W, Kobbuaklee S, Kansuwan P, Wudhikarn K, Rojnuckarin P, et al. Laboratory Concordance and Prognostic Impact of 10‐Color Flow Cytometry and Next‐Generation Sequencing‐Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B‐Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group ( TALWG ). International Journal of Laboratory Hematology. 2026;48(6):1418-1427. doi:10.1111/ijlh.70216

BibTeX
@article{Chanswangphuwana2026,
  author = {Chanswangphuwana, Chantiya and Limvorapitak, Wasithep and Kobbuaklee, Sirorat and Kansuwan, Patsita and Wudhikarn, Kitsada and Rojnuckarin, Ponlapat and Owattanapanich, Weerapat and Rattanathammethee, Thanawat and Tantiworawit, Adisak and Silpsamrit, Panachai and Prayongratana, Kannadit and Piyajaroenkij, Thanakrit and Jit-Ueakul, Dusit and Polprasert, Chantana},
  title = {Laboratory Concordance and Prognostic Impact of 10‐Color Flow Cytometry and Next‐Generation Sequencing‐Based Immunoglobulin Gene Assay for Measurable Residual Disease Monitoring in Adult B‐Cell Acute Lymphoblastic Leukemia: A Multicenter Study From Thai Acute Leukemia Working Group ( TALWG )},
  journal = {International Journal of Laboratory Hematology},
  year = {2026},
  volume = {48},
  number = {6},
  pages = {1418--1427},
  doi = {10.1111/ijlh.70216}
}
Kostenlos starten →